BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 10430421)

  • 1. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.
    Breitner JC; Wyse BW; Anthony JC; Welsh-Bohmer KA; Steffens DC; Norton MC; Tschanz JT; Plassman BL; Meyer MR; Skoog I; Khachaturian A
    Neurology; 1999 Jul; 53(2):321-31. PubMed ID: 10430421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.
    Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC;
    Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of AD may decline in the early 90s for men, later for women: The Cache County study.
    Miech RA; Breitner JC; Zandi PP; Khachaturian AS; Anthony JC; Mayer L
    Neurology; 2002 Jan; 58(2):209-18. PubMed ID: 11805246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic Alzheimer's disease.
    Combarros O; Leno C; Oterino A; Berciano J; Fernández-Luna JL; Fernández-Viadero C; Peña N; Miró J; Delgado M
    Acta Neurol Scand; 1998 Jan; 97(1):68-71. PubMed ID: 9482681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
    Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
    J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
    Drigalenko E; Poduslo S; Elston R
    Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
    Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.
    Tsuang D; Larson EB; Bowen J; McCormick W; Teri L; Nochlin D; Leverenz JB; Peskind ER; Lim A; Raskind MA; Thompson ML; Mirra SS; Gearing M; Schellenberg GD; Kukull W
    Arch Neurol; 1999 Dec; 56(12):1489-95. PubMed ID: 10593304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.
    Slooter AJ; Tang MX; van Duijn CM; Stern Y; Ott A; Bell K; Breteler MM; Van Broeckhoven C; Tatemichi TK; Tycko B; Hofman A; Mayeux R
    JAMA; 1997 Mar; 277(10):818-21. PubMed ID: 9052712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.
    Blue EE; Cheng A; Chen S; Yu CE;
    JAMA Netw Open; 2020 Oct; 3(10):e2017666. PubMed ID: 33090224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.
    Bennett DA; Wilson RS; Schneider JA; Evans DA; Aggarwal NT; Arnold SE; Cochran EJ; Berry-Kravis E; Bienias JL
    Neurology; 2003 Jan; 60(2):246-52. PubMed ID: 12552039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
    Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
    Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.